CUE BIOPHARMA INC. - COMMON STOCK

Cue Biopharma to Host Business Update Call and Webcast

02 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Cue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium

29 2月 2024 09:00:00 条件 Nasdaq GlobeNewswire

Cue Biopharma to Present Corporate Update at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

06 2月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Cue Biopharma to Present at the JMP Securities Hematology and Oncology Summit

22 11月 2023 07:00:00 条件 Nasdaq GlobeNewswire

Cue Biopharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights

09 11月 2023 15:05:02 条件 Nasdaq GlobeNewswire

Cue Biopharma to Present at Three Upcoming Investor Healthcare Conferences in November

07 11月 2023 07:00:00 条件 Nasdaq GlobeNewswire

Cue Biopharma Presents New Positive Data from Phase 1 Trials of CUE-101 in Head and Neck Cancer and CUE-102 in Wilms’ Tumor 1 Positive Cancers at SITC 2023

03 11月 2023 11:00:00 条件 Nasdaq GlobeNewswire

Cue Biopharma to Host Business Update Call and Webcast

02 11月 2023 07:00:00 条件 Nasdaq GlobeNewswire

Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting

27 9月 2023 08:05:00 条件 Nasdaq GlobeNewswire

Cue Biopharma Announces Completion of Patient Enrollment in Phase 1b Study of CUE-101 in Combination with KEYTRUDA®

26 9月 2023 07:00:01 条件 Nasdaq GlobeNewswire

Cue Biopharma Reports Second Quarter 2023 Financial Results and Recent Business Highlights

09 8月 2023 15:10:00 条件 Nasdaq GlobeNewswire

Cue Biopharma to Host Business Update Call and Webcast

02 8月 2023 07:00:01 条件 Nasdaq GlobeNewswire

Cue Biopharma to Present at the Federation of Clinical Immunology Societies (FOCIS) 2023 Annual Meeting

14 6月 2023 07:00:01 条件 Nasdaq GlobeNewswire

Cue Biopharma to Host Investor Call

07 6月 2023 07:00:02 条件 Nasdaq GlobeNewswire

Cue Biopharma to Present at the Jefferies 2023 Global Healthcare Conference

05 6月 2023 07:00:01 条件 Nasdaq GlobeNewswire

Cue Biopharma Presents Positive Data Update from Ongoing Phase 1 Trials of CUE-101 for Recurrent/Metastatic HPV+ Head and Neck Squamous Cell Carcinoma at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

25 5月 2023 16:00:00 条件 Nasdaq GlobeNewswire

Cue Biopharma to Present at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

15 5月 2023 07:00:01 条件 Nasdaq GlobeNewswire

Cue Biopharma Reports First Quarter 2023 Financial Results and Recent Business Highlights

09 5月 2023 15:35:00 条件 Nasdaq GlobeNewswire

Cue Biopharma to Present at the Upcoming JMP Securities Life Sciences Conference

08 5月 2023 07:00:01 条件 Nasdaq GlobeNewswire

Cue Biopharma Welcomes Seasoned Pharmaceutical Executive Pamela D. Garzone, Ph.D., to its Board of Directors

25 4月 2023 07:00:01 条件 Nasdaq GlobeNewswire